Results 91 to 100 of about 31,914 (284)

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation. [PDF]

, 2015
Stroke is a leading cause of morbidity and mortality worldwide. Atrial fibrillation (AF) is an independent risk factor for stroke, increasing the risk five-fold.
Andreotti, F, Camm, AJ, Hankey, GJ, Hobbs, FD, Pinto, FJ, Writing Committee of the Action for Stroke Prevention alliance   +5 more
core   +1 more source

Pharmacological profile of non-vitamin K antagonist oral anticoagulants [PDF]

African Journal of Pharmacy and Pharmacology, 2017
The non-vitamin K antagonist oral anticoagulants have been approved since 2008 for the prevention of systemic embolism and stroke in patients with non-valvular atrial fibrillation with prior stroke, transient ischemic attack, or CHA2DS2-VASc score ≥2.
openaire   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation

Anatolian Journal of Cardiology, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease.
Anetta Undas, Leszek Drabik
doaj   +1 more source

Is this the beginning of end for warfarin in bioprosthetic mitral valve recipients with atrial fibrillation? – New insights from RIVER trial

Indian Heart Journal, 2021
Novel oral anticoagulants, with dabigatran in particular have failed in their quest to replace the traditional anticoagulation in the form of vitamin K antagonist in patients with mechanical valvular implants.
Ankit Kumar Sahu, Arpita Katheria
doaj   +1 more source

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry [PDF]

, 2019
In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs).
Boriani, Giuseppe, Dan, Gheorghe-Andrei, EORP-AF Long-Term General Registry Investigators, Evrard, Patrick, Fauchier, Laurent, Kalarus, Zbigniew, Laroche, Cécile, Lip, Gregory Y H, Maggioni, Aldo P, Marin, Francisco, Nabauer, Michael, Potpara, Tatjana, Proietti, Marco, Tavazzi, Luigi   +13 more
core   +1 more source

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects

International Journal of Cancer, EarlyView.
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander, Alessandra I. G. Buma, Jenneke Leentjens, Paddy K. C. Janssen, Michel M. van den Heuvel, David M. Burger, Berber Piet, Rob ter Heine   +7 more
wiley   +1 more source

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants

Clinical Interventions in Aging, 2015
Mohit K Turagam, Poonam Velagapudi, Greg C FlakerDivision of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO, USAAbstract: Stroke prevention in elderly atrial fibrillation patients remains a challenge.
Turagam MK, Velagapudi P, Flaker GC
doaj  

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants

Advances in Hematology, 2020
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban.
Mark Terence P. Mujer, Manoj P. Rai, Varunsiri Atti, Ian Limuel Dimaandal, Abigail S. Chan, Shiva Shrotriya, Krishna Gundabolu, Prajwal Dhakal   +7 more
doaj   +1 more source

Systematic Review of Medicine-Related Problems in Adult Patients with Atrial Fibrillation on Direct Oral Anticoagulants [PDF]

, 2017
New oral anticoagulant agents continue to emerge on the market and their safety requires assessment to provide evidence of their suitability for clinical use.
Adusumilli, P.K., Adepu, R.,, Al Hamid, A., Ghaleb, M., Aljadhey, H., Aslanpour, Z.,, Alhomoud, F., Dhillon, S., Aslanpour, Z., Smith, F.,, Andreica, I., Grissinger, M.,, Basger, B. J., Moles, R. J., Chen, T. F.,, Bauer, K. A.,, Beijer HJ,, Beyer-Westendorf, J., Ebertz, F., Foerster, K., Gelbricht, V., Michalski, F., Köhler, C., Werth, S., Endig, H., Pannach, S., Tittl, L., Sahin, K., Daschkow, K., Weiss, N.,, Caldeira, D., Barra, M., Santos, A. T., de Abreu, D., Pinto, F.J., Ferreira, J.J., Costa, J.,, Caldeira, D., Canastro, M., Barra, M., Ferreira, A., Costa, J., Pinto, F.J., Ferreira, J.J.,, Caldeira, D., Gonçalves, N., Pinto, F. J., Costa, J., Ferreira, J.J.,, Camm, A. J., Lip, G. Y., De Caterina, Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., Chan, Y. H., Yen, K. C., See, L. C., Chang, S.H., Wu, L.S., Lee, H.F., Tu, H.T., Yeh, Y.H., Kuo, C.T.,, Chang, H. Y., Zhou, M., Tang, W., Alexander, G.C., Singh, S.,, Chatterjee, S., Sardar, P., Giri, J. S., Ghosh, J., Mukherjee, D.,, Crowther, M. A., Warkentin, T. E., Cutler, T. W., Chuang, A., Huynh, T. D., Witt, R.G., Branch, J., Pon, T., White R.,, Dentali, F., Riva, N., Crowther, Turpie, A.G., Lip, G.Y., Ageno, W.,, Dentali, F., Sironi, A. P., Gianni, M., Orlandini, F., Guasti, L., Grandi, A.M., Franchini, M., Ageno, W., Squizzato, A.,, Donaldson, M., Norbeck, A. O., Forslund, T., Wettermark, B., Hjemdahl, P., Gorst-Rasmussen, A., Skjøth, F., Larsen, T. B., Rasmussen, L.H., Lip, G.Y., Lane, D.A.,, Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M.R., Levenson, M., Sheu, T.C., Mott, K., Goulding, M.R., Houstoun, M., MaCurdy, T.E., Worrall, C., Kelman, J.A.,, Ho, M. H., Ho, C. W., Cheung, E., Chan, P.H., Hai, J.J., Chan, K.H., Chan, E.W., Leung, G.K., Tse, H.F., Siu, C.W.,, Holster, I. L., Valkhoff, V. E., Kuipers, E. J., Tjwa, ETTL,, Hu, Y. F., Liao, J. N., Chern, C. M., Weng, C.H., Lin, Y.J., Chang, S.L., Wu, C.H., Sung, S.H., Wang, K.L., Lu, T.M., Chao, T.F., Lo, L.W., Chung, F.P., Hsu, L.C., Chen, S.A.,, Hughes, R. G., Blegen, M. A., Landefeld, C. S., Beyth, R. J., Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K.M., Callréus, T., Rosenzweig, M., Lip, G.Y.,, Lee, P. Y., Han, S. Y., Miyahara, R. K., Lega, J. C., Bertoletti, L., Gremillet, C., Chapelle, C., Mis-metti, P., Cucherat, M., Vital-Durand, D., Laporte, S.,, Martinez, C., Katholing, A., Wallenhorst, C., Freedman, S.B.,, Mekaj, Y. H., Mekaj, A. Y., Duci, S. B., Miftari, E.I.,, Miller, C. S., Grandi, S. M., Shimony, A., Filion, K. B., & Eisenberg, M. J., Monteagudo, M., Fernández-Díaz, E., García-García, J., Ayo-Martín, O., Hernández-Fernández, F., Segura, T.,, Nishtala, P. S., Gnjidic, D., Jamieson, H. A., Hanger, H.C., Kaluarachchi, C., Hilmer, S.N.,, Plovanich, M., Mostaghimi, A.,, Saedder, E. A., Brock, B., Nielsen, L. P., Bonnerup, D.K., Lisby, M.,, Sardar, P., Chatterjee, S., Chaudhari, S., Lip, G.Y.,, Sardar, P., Chatterjee, S., Lavie, C.J., Giri, J.S., Ghosh, J., Mukherjee, D., Lip, G.Y., Scridon, A., Constantin, S. R.,, Strand, L, Morley P, Cipolle R, et al., Thorne, K., Jayathissa, S., Dee, S., Briggs, N., Taylor J., Reid, S., De Silva, K., Dean, J.,, Van den Bemt, P. M. L. A., Egberts, A. C. G., Van Mil, J. F., Westerlund, L. T., Hersberger, K. E., Schaefer, M.A.,   +44 more
core   +2 more sources